3 reports of this reaction
9.4% of all POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL reports
#1 most reported adverse reaction
CATARACT is the #1 most commonly reported adverse reaction for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, manufactured by Wal-Mart Stores, Inc.. There are 3 FDA adverse event reports linking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL to CATARACT. This represents approximately 9.4% of all 32 adverse event reports for this drug.
Patients taking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL who experience cataract should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CATARACT is moderately reported among POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL users, representing a notable but not dominant share of adverse events.
In addition to cataract, the following adverse reactions have been reported for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL:
The following drugs have also been linked to cataract in FDA adverse event reports:
CATARACT has been reported as an adverse event in 3 FDA reports for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
CATARACT accounts for approximately 9.4% of all adverse event reports for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, making it one of the most commonly reported side effect.
If you experience cataract while taking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.